NOBL vs XLV
ProShares S&P 500 Dividend Aristocrats ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.35% for NOBL.
- • NOBL pays a higher dividend yield (1.98%).
Side-by-side metrics
| Metric | NOBL | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.98% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $11.90B | $49.10B |
YTD return | 18.41% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.52 | 0.41 |
P/E ratio | 21.73 | 30.63 |
Last price | $60.53 | $187.94 |
Inception | — | — |
Issuer | ProShares | State Street |
NOBL top holdings
| ROP | Roper Technologies Inc | 1.91% |
| FDS | FactSet Research Systems Inc | 1.85% |
| BDX | Becton Dickinson & Co | 1.78% |
| IBM | International Business Machines Corp | 1.73% |
| ERIE | Erie Indemnity Co Class A | 1.71% |
| CVX | Chevron Corp | 1.68% |
| XOM | ExxonMobil Holdings Corp | 1.67% |
| ADP | Automatic Data Processing Inc | 1.67% |
| EMR | Emerson Electric Co | 1.63% |
| MDT | Medtronic PLC | 1.63% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About NOBL
NOBL (ProShares S&P 500 Dividend Aristocrats ETF) is S&P 500 names with 25+ years of dividend growth. Managed by ProShares, the fund carries $11.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 1.98%. Its largest holding is Roper Technologies Inc (ROP), which represents 1.9% of the portfolio. Real Estate is the fund's largest sector exposure at 3.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.